Your browser is no longer supported. Please, upgrade your browser.
XBI SPDR S&P Biotech ETF daily Stock Chart
SPDR S&P Biotech ETF
Index- P/E- EPS (ttm)- Insider Own- Shs Outstand- Perf Week6.85%
Market Cap- Forward P/E- EPS next Y- Insider Trans- Shs Float- Perf Month-2.99%
Income- PEG- EPS next Q- Inst Own- Short Float- Perf Quarter14.60%
Sales- P/S- EPS this Y- Inst Trans- Short Ratio3.85 Perf Half Y-19.52%
Book/sh- P/B- EPS next Y- ROA- Target Price- Perf Year-27.73%
Cash/sh- P/C- EPS next 5Y- ROE- 52W Range44.16 - 90.86 Perf YTD-20.40%
Dividend0.41 P/FCF- EPS past 5Y- ROI- 52W High-38.50% Beta-
Dividend %0.73% Quick Ratio- Sales past 5Y- Gross Margin- 52W Low26.54% ATR1.68
Employees- Current Ratio- Sales Q/Q- Oper. Margin- RSI (14)61.44 Volatility2.73% 3.29%
OptionableYes Debt/Eq- EPS Q/Q- Profit Margin- Rel Volume1.03 Prev Close54.81
ShortableYes LT Debt/Eq- Earnings- Payout- Avg Volume7.06M Price55.88
Recom- SMA205.92% SMA505.02% SMA200-9.47% Volume7,289,379 Change1.95%
May-23-16 05:44PM  Markets Rise as Fed Member James Bullard Exhibits Hawkish Stance
May-19-16 12:16PM  XBI Large-Caps: Why Is BioMarin Inching Higher?
12:16PM  Markets Are Defensive: XBI Outperforms the Market
May-17-16 11:40AM  Biotech ETFs Soar on Pfizer-Anacor Deal: SBIO, XBI in Lead
May-16-16 10:07AM  Analyzing XBI Mid-Caps: Intrexon Fell Due to 1Q16 Loss
10:06AM  What Do Analysts Recommend for Medivation?
May-13-16 04:48PM  What Lies Ahead for Biotech ETFs?
May-12-16 12:13PM  Inside XBI Large-Caps: European Commission Approves of Empliciti
12:13PM  XBI Dropped, Markets Fell Due to Retail Sector Concerns
May-10-16 04:13PM  Why Did Medivations Share Price Increase so Much after Earnings?
07:00AM  The Trader Daily: Lots of Stocks Get Drilled at TheStreet
07:00AM  The Trader Daily: Lots of Stocks Get Drilled
May-09-16 06:24PM  Healthcare, Biotech SPDR Indexes Gain on May 9 as US Dollar Rises
04:21PM  Why Celldex Therapeutics, Inc. Popped Today at Motley Fool
12:08PM  IHI Bucks the Downward Trend for the Week Ending May 6
May-06-16 10:07AM  Inside XBIs Mid Caps: Ionis Crashes on 1Q16 Earnings Report Market Realist
May-05-16 05:56PM  Inside XBIs Large Caps: Incyte Pulls Down Large Caps on Earnings Concerns Market Realist
09:17AM  How beaten-up Mr. Market still could rise up to a new high at MarketWatch
May-04-16 06:07PM  Inside Soliriss Continued Growth Momentum Market Realist
04:13PM  [$$] Sarepta: A High-Risk, High-Return Trade at
02:05PM  XBIs Mid Caps: Ionis Gives Update on Nusinersen Phase 2 Study Market Realist
02:04PM  Ioniss Metabolic Segment: Phase I and Phase II Studies Market Realist
Apr-28-16 04:56PM  Is XBI Heading Back to Where It Started in April? Market Realist
03:04AM  Opportunities For Xtandi, Medivations Key Drug Market Realist
Apr-27-16 06:08PM  Energy-Related Stocks Rose after FOMC Decision Market Realist
Apr-25-16 09:00AM  Trader's Notebook: Responding to the Move in Dollar Futures at TheStreet
Apr-22-16 09:00AM  Trader's Notebook: Searching for Bullish Excess in the Banks at TheStreet
Apr-21-16 04:51PM  Rising Dollar Offsets Crude Prices as Major SPDR Indexes Fall Market Realist
11:06AM  XBIs Large Caps: BioMarin Gives Update on Gene Therapy Study Market Realist
11:02AM  How Does XBI Compare to Its 100-Day Moving Average? Market Realist
Apr-19-16 05:40PM  SPDR Indexes across Energy and Gold Rise on Increase in Commodities
09:06AM  What Do Analysts Recommend for Medivation?
07:10AM  Return Of The Mack: This Biotech ETF Is Back
Apr-18-16 05:18PM  Recovery in Crude Prices Lifts Energy and Healthcare SPDR Indexes
Apr-15-16 10:39AM  XBI Holdings Finished Strong as Market Bounced Back on April 13
Apr-14-16 04:56PM  US Dollar Is Strong despite Inflation Releasing below Forecast
02:46PM  Analyst Estimates for Ionis Pharmaceuticals 2016 Revenue
Apr-11-16 03:14PM  Large-Cap News: Edwards Surged on SAPIENT 3 TAVR Data
03:14PM  Among Biotechnology ETFs, XBI Dominated the 1st Week of April
Apr-09-16 12:06AM  XBI Mid Caps: Alnylam to Present at Needham Healthcare Conference
Apr-08-16 11:18PM  Last Week's Best Healthcare ETF at Motley Fool
Apr-07-16 04:07PM  Incyte Continues Its Growth Spree in 2015
03:04PM  XBI Large Caps: Incyte Signs Deal with Eli Lilly
12:30PM  A Leader-Laggard Long-Short ETF Pair Trade
11:30AM  Biotech Regain Health: ETFs to Prescribe
Apr-06-16 08:15AM  Inklings Of Upside For A Leveraged Biotech ETF +7.02%
Apr-05-16 03:02PM  US Markets Fall despite Rising Non-Manufacturing PMI
02:50PM  Dont Buy The Greatest Fools Theory Of Investment Value
10:36AM  Biotechnology ETFs: Who Were the Top Performers Last Week?
09:40AM  Broad weakness at open: Pisani
Apr-02-16 03:06PM  Why You Should Exercise Caution When Investing in Healthcare
12:30PM  Looking for Sunshine in Biotech's Gloomy First-Quarter Performance at TheStreet
12:13PM  Last Week's Best Healthcare ETF at Motley Fool
Apr-01-16 05:13PM  Positive Market Sentiment as Non-Farm Payroll Beats Expectations
01:08PM  Will Elagolix Make Neurocrine Biosciences a Key Womens Health Name?
12:52PM  Why It's Been a Wild Few Days for Genocea Biosciences Inc. at Motley Fool
Mar-31-16 04:39PM  US Markets Flat as Unemployment Claims Rise
12:07PM  This Indicator Suggests A Bear Market Is Now Underway And Its Likely To Be A Painful One
09:54AM  Biotech Stocks Offer a Greater Risk-to-Reward Trade-Off
09:54AM  Yellens Caution Led Battered Healthcare Up 1.2% on March 29
Mar-29-16 07:06PM  XBI Mid-Cap News: Look Who Took a Beating on March 23
12:56PM  Why It Still Feels Like We're in a Bear Market: Risk Sentiment Is Nowhere to Be Found at TheStreet
Mar-24-16 06:23PM  XBI Large-Cap News: Amid Beatdowns, Regeneron Has an Announcement
06:23PM  Whats Got XBI Down?
11:39AM  US Markets Traded Low as Commodity Prices Fell
Mar-23-16 09:00AM  Trader's Notebook: Biotech Has Momentum -5.01%
Mar-22-16 04:19PM  US Markets Rebound after Brussels Attack: Gold Trades Higher
01:28PM  Curb Your Enthusiasm With the Biotech Bounce at Investopedia
01:05AM  XBI News as of March 16: Mid-Caps Under Pressure
Mar-21-16 12:35PM  Biotech ETFs Show Encouraging Sign; Gold ETF Continues To Struggle
Mar-17-16 01:42PM  XBI on a Downward Slope, but How Steep?
Mar-16-16 06:35PM  FOMC: Less Hawkish Stance amid Concerns about Global Growth
09:00AM  Trader's Notebook: Get Ready for the Old FOMC 'Reverse'
07:00AM  The Trader Daily: Valeant's Crash Scatters Debris
Mar-15-16 05:17PM  US Markets Dip as Retail Sales Fall before FOMC Meeting -5.78%
Mar-14-16 06:55PM  Gold ETF Slumps As Major Indexes Finish Mixed; IBB In Sell Range
04:48PM  US Markets Show Marginal Gains as Investors Display Caution
Mar-10-16 09:00AM  Trader's Notebook: I Favor a More Bearish Posture on Miners
05:58AM  Gilead Sciences Is a Buy Now at TheStreet
Mar-09-16 04:04PM  Energy and Mining SPDR Funds Rally as Precious Metals Exhibit Decline
Mar-08-16 09:00AM  Trader's Notebook: Is It Time to Short Netflix and Facebook? -5.22%
06:55AM  What Led Advaxis to Top XBI with a 49% Gain?
Mar-07-16 08:07AM  XBIs Mid-Cap Stocks Outperformed Large Caps
Mar-05-16 02:00PM  Last Week's Best Healthcare ETF at Motley Fool
12:00PM  So Many Topics, So Few Columns
Mar-04-16 09:00AM  Trader's Notebook: Is It Biotech's Turn to Outperform?
Mar-03-16 06:19PM  Your first trade for Friday, March 4 at CNBC
05:58PM  Final Trade: Apple, The Fresh Market, & more
03:03PM  Energy and Mining SPDRs Rally as Services Sector Declines
Mar-02-16 04:10PM  Biotech: 'A Crowded Trade in the Midst of Unwinding' at
Mar-01-16 03:01PM  Upbeat Macro Releases: Enough for a Rally in Banking SPDRs?
09:00AM  Trader's Notebook: No Cure for Biotechs Ills
Feb-29-16 09:43PM  Is The Biotech Bear Market Over? at Forbes
Feb-26-16 04:14PM  Banking SPDRs Got a Boost while Utility ETFs Traded Lower
Feb-25-16 08:07AM  XBIs Large-Cap Stocks Ended Lower: How Did They Perform?
Feb-24-16 11:02AM  How Did Ziopharm Keep XBI from Losing More Ground?
11:00AM  Biotech Investors Shouldn't Fear Legislation, Even If Hillary Is President And Dems Win Senate Majority
Feb-19-16 08:50AM  Some Traders Aren't Shy About Betting On A Biotech Rebound
Feb-16-16 01:33PM  Is the worst ETF of 2016 about to get even worse? at CNBC
Feb-09-16 08:14PM  Transportation, Jets ETFs Speed Up As Oil Falls Below $28
The investment seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the S&P Biotechnology Select Industry Index derived from the biotechnology segment of a U.S. total market composite index. In seeking to track the performance of the S&P Biotechnology Select Industry Index (the "index"), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the biotechnology industry group of the S&P Total Market Index ("S&P TMI"). The fund is non-diversified.